Soligenix Announces Recent Accomplishments and Second Quarter 2016 Financial...
PRINCETON N.J. Aug. 11 2016 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleDermatopathology more common in crohn's than ulcerative colitis
HealthDayCutaneous manifestations of inflammatory bowel disease IBD should be considered when reviewing unexplained skin lesions particularly in patients with Crohn's disease CD according to research...
View ArticleRedHill Biopharma Provides 2016 SemiAnnual R&D Update
TelAviv Israel August 11 2016 B3C newswire RedHill Biopharma Ltd. NASDAQ RDHL TASE RDHL RedHill or the Company a biopharmaceutical company primarily focused on development and commercialization of late...
View ArticleRedHill Biopharma Provides 2016 SemiAnnual R&D Update
TELAVIV Israel Aug. 11 2016 GLOBE NEWSWIRE RedHill Biopharma Ltd. NASDAQRDHL TASERDHL "RedHill" or the "Company" a biopharmaceutical company primarily focused on...
View ArticleProtagonist raises $90M in bumpedup IPO
Protagonist Therapeutics Inc. NASDAQPTGX dipped $0.30 to $11.70 in its first day of trading Thursday after it raised $90 million through the sale of 7.5 million shares at $12 in an IPO. Leerink...
View ArticleBioTherapeutics and Virginia Tech Creating "Health" Water
About a decade ago as consumers were just learning that some types of bacteria are essential to good health and started buying food with probiotics Josep BassaganyaRiera CEO of BioTherapeutics began to...
View ArticleArena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief...
SAN DIEGO Aug. 15 2016 PRNewswire &160;Arena Pharmaceuticals Inc. NASDAQ ARNA announced that Vincent Aurentz will join its management team as Executive Vice President and Chief Business Officer...
View ArticleLast Chance to Submit Abstract for 2016 Advances in Inflammatory Bowel...
NEW YORK Aug. 15 2016 PRNewswireUSNewswire Increase your prestige and gain exposure of your work by submitting an abstract for the 2016 Advances in Inflammatory Bowel Diseases AIBD Conference the...
View ArticleImmune Pharmaceuticals Provides Business and R&D Update and Announces Second...
NEW YORK Aug. 16 2016 PRNewswire &160;Immune Pharmaceuticals Inc. NASDAQIMNP "Immune" or the "Company" announced financial results for the second quarter and six months ended June 30 2016 as well...
View ArticleStem Cells May Help Patients With Refractory Crohn's Disease
Mesenchymal stem cells MSCs may help treat complex perianal fistulas in patients with Crohn's disease who don't respond to conventional or biological treatments new research shows. Reuters Health...
View ArticleLab team spins ginger into nanoparticles to heal inflammatory bowel disease
Veterans Affairs Research Communications Researchers with the Department of Veterans Affairs and the Institute for Biomedical Sciences at Georgia State University have developed 'edible gingerderived...
View ArticleEngineered stem cells can deliver antibodies more effectively says U of T...
U of T professor John E. Davies partnered with other Canadian researchers on the stem cell study Luke Ng photo SOURCE August 2016Â Vaccines and antibodies have long been employed as weapons in the...
View ArticleAdipose Mesenchymal Stem Cells Are Effective for Complex Perianal Fistulas in...
Half of patients had complete closure of all external openings 24 weeks after treatment with stem cells.
View ArticleGinger Nanoparticles Heal Inflammatory Bowel Disease
Investigators at the Atlanta Veterans Affairs Medical Center and Georgia State University have been rummaging through the local farmer&39;s markets in the search for a healthy supply of an unlikely...
View ArticleJoint Pain and Crohn’s Disease
A Crohns disease patient who complains of joint pain should first be queried as to the location character presence or absence of inflammatory features associated musculoskeletal features of a...
View ArticlePlantbased nanoparticles successfully treat inflammatory bowel disease in...
There is a clinical need for new more effective treatments for chronic and debilitating inflammatory bowel disease IBD including Crohn&8217;s disease and ulcerative colitis. Now a study from...
View ArticleCME Outfitters Announces New Live and On Demand Activity on IBD
CME Outfitters to host live webcast on Inflammatory Bowel Diseases with interactive Q&A session following on September 8th.Bethesda MD PRWEB August 18 2016 CME Outfitters CMEO a leading...
View ArticleSaving the Day for those with IBD
Who said the pharmaceutical industry isnt innovative when it comes to communicating with patients A new graphic novel and superhero devised as part of a first of its kind collaboration looks set to...
View ArticleLycera Announces Initiation of Phase 2 Clinical Trial of LYC30937EC in...
NEW YORK and ANN ARBOR Mich. Aug. 22 2016 PRNewswire &160;Lycera Corp. a privately held biopharmaceutical company developing breakthrough immune modulatory medicines announced today the initiation...
View Article